Press Releases

Date	Title	PDF Version
May 11, 2017	Alexion Global Headquarters Earns Highest LEED® Green Building Certification
May 09, 2017	Alexion to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
Apr 27, 2017	Alexion Reports First Quarter 2017 Results
Apr 06, 2017	Alexion to Report First Quarter 2017 Results on Thursday, April 27, 2017
Mar 27, 2017	Alexion Appoints Ludwig Hantson, Ph.D., as Chief Executive Officer
Mar 22, 2017	Alexion Submits Application in Japan for Soliris® (Eculizumab) as a Potential Treatment for Patients with Refractory Generalized Myasthenia Gravis (gMG)
Mar 08, 2017	FDA Accepts sBLA Filing of Soliris® (Eculizumab) as a Potential Treatment for Patients with Refractory Generalized Myasthenia Gravis (gMG)
Mar 02, 2017	Leonard Bell, M.D., Alexion's Founder, Announces Plans to Retire as Chairman and Board Member
Feb 27, 2017	Alexion to Present at Upcoming Investor Conferences
Feb 16, 2017	Alexion Reports Fourth Quarter and Full Year 2016 Results and Provides Financial Guidance for 2017

Search